Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods

Abstract Antimicrobial peptides, such as bacteriocin, produced by probiotics have become a promising novel class of therapeutic agents for treating infectious diseases. Selected lactic acid bacteria (LAB) isolated from fermented foods with probiotic potential were evaluated for various tests, includ...

Full description

Bibliographic Details
Main Authors: Tran Thi Dieu Thuy, Hsu-Feng Lu, Carl Jay Ballena Bregente, Fong-Chi Annabelle Huang, Pei-Chun Tu, Cheng-Yen Kao
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Microbiology
Subjects:
Online Access:https://doi.org/10.1186/s12866-024-03245-0
_version_ 1797259539266928640
author Tran Thi Dieu Thuy
Hsu-Feng Lu
Carl Jay Ballena Bregente
Fong-Chi Annabelle Huang
Pei-Chun Tu
Cheng-Yen Kao
author_facet Tran Thi Dieu Thuy
Hsu-Feng Lu
Carl Jay Ballena Bregente
Fong-Chi Annabelle Huang
Pei-Chun Tu
Cheng-Yen Kao
author_sort Tran Thi Dieu Thuy
collection DOAJ
description Abstract Antimicrobial peptides, such as bacteriocin, produced by probiotics have become a promising novel class of therapeutic agents for treating infectious diseases. Selected lactic acid bacteria (LAB) isolated from fermented foods with probiotic potential were evaluated for various tests, including exopolysaccharide production, antibiotic susceptibility, acid and bile tolerance, antibacterial activity, and cell adhesion and cytotoxicity to gastric cell lines. Six selected LAB strains maintained their high viability under gastrointestinal conditions, produced high exopolysaccharides, showed no or less cytotoxicity, and adhered successfully to gastric cells. Furthermore, three strains, Weissella confusa CYLB30, Lactiplantibacillus plantarum CYLB47, and Limosilactobacillus fermentum CYLB55, demonstrated a strong antibacterial effect against drug-resistant Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella enterica serovar Choleraesuis, Enterococcus faecium, and Staphylococcus aureus. Whole genome sequencing was performed on these three strains using the Nanopore platform; then, the results showed that all three strains did not harbor genes related to toxins, superantigens, and acquired antimicrobial resistance, in their genome. The bacteriocin gene cluster was found in CYLB47 genome, but not in CYLB30 and CYLB55 genomes. In SDS-PAGE, the extract of CYLB30 and CYLB47 bacteriocin-like inhibitory substance (BLIS) yielded a single band with a size of less than 10 kDa. These BLIS inhibited the growth and biofilm formation of drug-resistant P. aeruginosa and methicillin-resistant S. aureus (MRSA), causing membrane disruption and inhibiting adhesion ability to human skin HaCaT cells. Moreover, CYLB30 and CYLB47 BLIS rescued the larvae after being infected with P. aeruginosa and MRSA infections. In conclusion, CYLB30 and CYLB47 BLIS may be potential alternative treatment for multidrug-resistant bacteria infections.
first_indexed 2024-04-24T23:11:02Z
format Article
id doaj.art-f25fbdd599ef4f4c9005bd27aef88c68
institution Directory Open Access Journal
issn 1471-2180
language English
last_indexed 2024-04-24T23:11:02Z
publishDate 2024-03-01
publisher BMC
record_format Article
series BMC Microbiology
spelling doaj.art-f25fbdd599ef4f4c9005bd27aef88c682024-03-17T12:17:19ZengBMCBMC Microbiology1471-21802024-03-0124111510.1186/s12866-024-03245-0Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foodsTran Thi Dieu Thuy0Hsu-Feng Lu1Carl Jay Ballena Bregente2Fong-Chi Annabelle Huang3Pei-Chun Tu4Cheng-Yen Kao5Institute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung UniversityDepartment of Laboratory Medicine, China Medical University HospitalInstitute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung UniversityTaipei American SchoolInstitute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung UniversityInstitute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung UniversityAbstract Antimicrobial peptides, such as bacteriocin, produced by probiotics have become a promising novel class of therapeutic agents for treating infectious diseases. Selected lactic acid bacteria (LAB) isolated from fermented foods with probiotic potential were evaluated for various tests, including exopolysaccharide production, antibiotic susceptibility, acid and bile tolerance, antibacterial activity, and cell adhesion and cytotoxicity to gastric cell lines. Six selected LAB strains maintained their high viability under gastrointestinal conditions, produced high exopolysaccharides, showed no or less cytotoxicity, and adhered successfully to gastric cells. Furthermore, three strains, Weissella confusa CYLB30, Lactiplantibacillus plantarum CYLB47, and Limosilactobacillus fermentum CYLB55, demonstrated a strong antibacterial effect against drug-resistant Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella enterica serovar Choleraesuis, Enterococcus faecium, and Staphylococcus aureus. Whole genome sequencing was performed on these three strains using the Nanopore platform; then, the results showed that all three strains did not harbor genes related to toxins, superantigens, and acquired antimicrobial resistance, in their genome. The bacteriocin gene cluster was found in CYLB47 genome, but not in CYLB30 and CYLB55 genomes. In SDS-PAGE, the extract of CYLB30 and CYLB47 bacteriocin-like inhibitory substance (BLIS) yielded a single band with a size of less than 10 kDa. These BLIS inhibited the growth and biofilm formation of drug-resistant P. aeruginosa and methicillin-resistant S. aureus (MRSA), causing membrane disruption and inhibiting adhesion ability to human skin HaCaT cells. Moreover, CYLB30 and CYLB47 BLIS rescued the larvae after being infected with P. aeruginosa and MRSA infections. In conclusion, CYLB30 and CYLB47 BLIS may be potential alternative treatment for multidrug-resistant bacteria infections.https://doi.org/10.1186/s12866-024-03245-0Antibacterial activityBacteriocin-like inhibitory substanceBiofilm formationMultidrug-resistant bacteriaProbiotic
spellingShingle Tran Thi Dieu Thuy
Hsu-Feng Lu
Carl Jay Ballena Bregente
Fong-Chi Annabelle Huang
Pei-Chun Tu
Cheng-Yen Kao
Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods
BMC Microbiology
Antibacterial activity
Bacteriocin-like inhibitory substance
Biofilm formation
Multidrug-resistant bacteria
Probiotic
title Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods
title_full Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods
title_fullStr Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods
title_full_unstemmed Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods
title_short Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods
title_sort characterization of the broad spectrum antibacterial activity of bacteriocin like inhibitory substance producing probiotics isolated from fermented foods
topic Antibacterial activity
Bacteriocin-like inhibitory substance
Biofilm formation
Multidrug-resistant bacteria
Probiotic
url https://doi.org/10.1186/s12866-024-03245-0
work_keys_str_mv AT tranthidieuthuy characterizationofthebroadspectrumantibacterialactivityofbacteriocinlikeinhibitorysubstanceproducingprobioticsisolatedfromfermentedfoods
AT hsufenglu characterizationofthebroadspectrumantibacterialactivityofbacteriocinlikeinhibitorysubstanceproducingprobioticsisolatedfromfermentedfoods
AT carljayballenabregente characterizationofthebroadspectrumantibacterialactivityofbacteriocinlikeinhibitorysubstanceproducingprobioticsisolatedfromfermentedfoods
AT fongchiannabellehuang characterizationofthebroadspectrumantibacterialactivityofbacteriocinlikeinhibitorysubstanceproducingprobioticsisolatedfromfermentedfoods
AT peichuntu characterizationofthebroadspectrumantibacterialactivityofbacteriocinlikeinhibitorysubstanceproducingprobioticsisolatedfromfermentedfoods
AT chengyenkao characterizationofthebroadspectrumantibacterialactivityofbacteriocinlikeinhibitorysubstanceproducingprobioticsisolatedfromfermentedfoods